Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.

Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies

Open access

Abstract

Background: High dietary intake or blood concentrations (as biomarkers of dietary intake) of vitamin C, carotenoids, and vitamin E have been associated with reduced risk of cardiovascular disease, cancer, and mortality, but these associations have not been systematically assessed. Objective: We conducted a systematic review and meta-analysis of prospective studies of dietary intake and blood concentrations of vitamin C, carotenoids, and vitamin E in relation to these outcomes. Design: We searched PubMed and Embase up to 14 February 2018. Summary RRs and 95% CIs were calculated with the use of random-effects models. Results: Sixty-nine prospective studies (99 publications) were included. The summary RR per 100-mg/d increment of dietary vitamin C intake was 0.88 (95% CI: 0.79, 0.98, I2 = 65%, n = 11) for coronary heart disease, 0.92 (95% CI: 0.87, 0.98, I2 = 68%, n = 12) for stroke, 0.89 (95% CI: 0.85, 0.94, I2 = 27%, n = 10) for cardiovascular disease, 0.93 (95% CI: 0.87, 0.99, I2 = 46%, n = 8) for total cancer, and 0.89 (95% CI: 0.85, 0.94, I2 = 80%, n = 14) for all-cause mortality. Corresponding RRs per 50-μmol/L increase in blood concentrations of vitamin C were 0.74 (95% CI: 0.65, 0.83, I2 = 0%, n = 4), 0.70 (95% CI: 0.61, 0.81, I2 = 0%, n = 4), 0.76 (95% CI: 0.65, 0.87, I2 = 56%, n = 6), 0.74 (95% CI: 0.66, 0.82, I2 = 0%, n = 5), and 0.72 (95% CI: 0.66, 0.79, I2 = 0%, n = 8). Dietary intake and/or blood concentrations of carotenoids (total, β-carotene, α-carotene, β-cryptoxanthin, lycopene) and α-tocopherol, but not dietary vitamin E, were similarly inversely associated with coronary heart disease, stroke, cardiovascular disease, cancer, and/or all-cause mortality. Conclusions: Higher dietary intake and/or blood concentrations of vitamin C, carotenoids, and α-tocopherol (as markers of fruit and vegetable intake) were associated with reduced risk of cardiovascular disease, total cancer, and all-cause mortality. These results support recommendations to increase fruit and vegetable intake, but not antioxidant supplement use, for chronic disease prevention.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ajcn/nqy097

Cites

157 of 157 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Flow chart of study selection. COPD, chronic obstructive pulmonary disease.
FIGURE 1 Flow chart of study selection. COPD, chronic obstructive pulmonary disease.CC BY-NC · PubMed Central
FIGURE 2 Dietary intake and blood concentrations of vitamin C and coronary heart disease: dose-response analyses. (A) Dietary vitamin C and coronary heart disease: linear dose-response analysis. The summary RR per 100 mg/d was 0.88 (95% CI: 0.79, 0.98, I2 = 65%, Pheterogeneity = 0.001, n = 11). (B) Vitamin C in blood and coronary heart disease: linear dose-response analysis. The summary RR per 50 µmol/L was 0.74 (95% CI: 0.65, 0.83, I2 = 0%, Pheterogeneity = 0.71, n = 4). (C) Dietary vitamin C and coronary heart disease: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin C and coronary heart disease (Pnonlinearity < 0.0001). (D) Vitamin C in blood and coronary heart disease: nonlinear dose-response analysis. There was no evidence of nonlinearity for vitamin C in blood and coronary heart disease (Pnonlinearity = 0.49). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.
FIGURE 2 Dietary intake and blood concentrations of vitamin C and coronary heart disease: dose-response analyses. (A) Dietary vitamin C and coronary heart disease: linear dose-response analysis. The summary RR per 100 mg/d was 0.88 (95% CI: 0.79, 0.98, I2 = 65%, Pheterogeneity = 0.001, n = 11). (B) Vitamin C in blood and coronary heart disease: linear dose-response analysis. The summary RR per 50 µmol/L was 0.74 (95% CI: 0.65, 0.83, I2 = 0%, Pheterogeneity = 0.71, n = 4). (C) Dietary vitamin C and coronary heart disease: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin C and coronary heart disease (Pnonlinearity < 0.0001). (D) Vitamin C in blood and coronary heart disease: nonlinear dose-response analysis. There was no evidence of nonlinearity for vitamin C in blood and coronary heart disease (Pnonlinearity = 0.49). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.CC BY-NC · PubMed Central
FIGURE 3 Dietary intake and blood concentrations of vitamin C and stroke: dose-response analyses. (A) Dietary vitamin C and stroke: linear dose-response analysis. The summary RR per 100 mg/d was 0.92 (95% CI: 0.87, 0.98, I2 = 68%, Pheterogeneity < 0.0001, n = 12). (B) Vitamin C in blood and stroke: linear dose-response analysis. The summary RR per 50 µmol/L was 0.70 (95% CI: 0.61, 0.81, I2 = 0%, Pheterogeneity = 0.41, n = 4). (C) Dietary vitamin C and stroke: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin C and stroke (Pnonlinearity < 0.0001). (D) Vitamin C in blood and stroke: nonlinear dose-response analysis. There was no evidence of nonlinearity for vitamin C in blood and stroke (Pnonlinearity = 0.16). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.
FIGURE 3 Dietary intake and blood concentrations of vitamin C and stroke: dose-response analyses. (A) Dietary vitamin C and stroke: linear dose-response analysis. The summary RR per 100 mg/d was 0.92 (95% CI: 0.87, 0.98, I2 = 68%, Pheterogeneity < 0.0001, n = 12). (B) Vitamin C in blood and stroke: linear dose-response analysis. The summary RR per 50 µmol/L was 0.70 (95% CI: 0.61, 0.81, I2 = 0%, Pheterogeneity = 0.41, n = 4). (C) Dietary vitamin C and stroke: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin C and stroke (Pnonlinearity < 0.0001). (D) Vitamin C in blood and stroke: nonlinear dose-response analysis. There was no evidence of nonlinearity for vitamin C in blood and stroke (Pnonlinearity = 0.16). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.CC BY-NC · PubMed Central
FIGURE 4 Dietary intake and blood concentrations of vitamin C and cardiovascular disease: dose-response analyses. (A) Dietary vitamin C and cardiovascular disease: linear dose-response analysis. The summary RR per 100 mg/d was 0.89 (95% CI: 0.85, 0.94, I2 = 27%, Pheterogeneity = 0.19, n = 10). (B) Vitamin C in blood and cardiovascular disease: linear dose-response analysis. The summary RR per 50 µmol/L was 0.76 (95% CI: 0.65, 0.87, I2 = 56%, Pheterogeneity = 0.05, n = 6). (C) Dietary vitamin C and cardiovascular disease: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin C and cardiovascular disease (Pnonlinearity < 0.0001). (D) Vitamin C in blood and cardiovascular disease: nonlinear dose-response analysis. There was no evidence of nonlinearity for vitamin C in blood and cardiovascular disease (Pnonlinearity = 0.26). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines. SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.
FIGURE 4 Dietary intake and blood concentrations of vitamin C and cardiovascular disease: dose-response analyses. (A) Dietary vitamin C and cardiovascular disease: linear dose-response analysis. The summary RR per 100 mg/d was 0.89 (95% CI: 0.85, 0.94, I2 = 27%, Pheterogeneity = 0.19, n = 10). (B) Vitamin C in blood and cardiovascular disease: linear dose-response analysis. The summary RR per 50 µmol/L was 0.76 (95% CI: 0.65, 0.87, I2 = 56%, Pheterogeneity = 0.05, n = 6). (C) Dietary vitamin C and cardiovascular disease: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin C and cardiovascular disease (Pnonlinearity < 0.0001). (D) Vitamin C in blood and cardiovascular disease: nonlinear dose-response analysis. There was no evidence of nonlinearity for vitamin C in blood and cardiovascular disease (Pnonlinearity = 0.26). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines. SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.CC BY-NC · PubMed Central
FIGURE 5 Dietary intake and blood concentrations of vitamin C and total cancer: dose-response analyses. (A) Dietary vitamin C and total cancer: linear dose-response analysis. The summary RR per 100 mg/d was 0.93 (95% CI: 0.87, 0.99, I2 = 46%, Pheterogeneity = 0.08, n = 8). (B) Vitamin C in blood and total cancer: linear dose-response analysis. The summary RR per 50 µmol/L was 0.74 (95% CI: 0.66, 0.82, I2 = 0%, Pheterogeneity = 0.49, n = 5). (C) Dietary vitamin C and total cancer: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin C and total cancer (Pnonlinearity = 0.007). (D) Vitamin C in blood and total cancer: nonlinear dose-response analysis. There was evidence of nonlinearity for vitamin C in blood and total cancer (Pnonlinearity = 0.006). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines. SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.
FIGURE 5 Dietary intake and blood concentrations of vitamin C and total cancer: dose-response analyses. (A) Dietary vitamin C and total cancer: linear dose-response analysis. The summary RR per 100 mg/d was 0.93 (95% CI: 0.87, 0.99, I2 = 46%, Pheterogeneity = 0.08, n = 8). (B) Vitamin C in blood and total cancer: linear dose-response analysis. The summary RR per 50 µmol/L was 0.74 (95% CI: 0.66, 0.82, I2 = 0%, Pheterogeneity = 0.49, n = 5). (C) Dietary vitamin C and total cancer: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin C and total cancer (Pnonlinearity = 0.007). (D) Vitamin C in blood and total cancer: nonlinear dose-response analysis. There was evidence of nonlinearity for vitamin C in blood and total cancer (Pnonlinearity = 0.006). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines. SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.CC BY-NC · PubMed Central
FIGURE 6 Dietary intake and blood concentrations of vitamin C and mortality: dose-response analyses. (A) Dietary vitamin C and mortality: linear dose-response analysis. The summary RR per 100 mg/d was 0.89 (95% CI: 0.85, 0.94, I2 = 80%, Pheterogeneity < 0.0001, n = 14). (B) Vitamin C in blood and mortality: linear dose-response analysis. The summary RR per 50 µmol/L was 0.72 (95% CI: 0.66, 0.79, I2 = 48%, Pheterogeneity = 0.06, n = 8). (C) Dietary vitamin C and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin C and mortality (Pnonlinearity < 0.0001). (D) Vitamin C in blood and mortality: nonlinear dose-response analysis. There was no evidence of nonlinearity for vitamin C in blood and mortality (Pnonlinearity = 0.90). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines. SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.
FIGURE 6 Dietary intake and blood concentrations of vitamin C and mortality: dose-response analyses. (A) Dietary vitamin C and mortality: linear dose-response analysis. The summary RR per 100 mg/d was 0.89 (95% CI: 0.85, 0.94, I2 = 80%, Pheterogeneity < 0.0001, n = 14). (B) Vitamin C in blood and mortality: linear dose-response analysis. The summary RR per 50 µmol/L was 0.72 (95% CI: 0.66, 0.79, I2 = 48%, Pheterogeneity = 0.06, n = 8). (C) Dietary vitamin C and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin C and mortality (Pnonlinearity < 0.0001). (D) Vitamin C in blood and mortality: nonlinear dose-response analysis. There was no evidence of nonlinearity for vitamin C in blood and mortality (Pnonlinearity = 0.90). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines. SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.CC BY-NC · PubMed Central
FIGURE 7 Dietary intake and blood concentrations of carotenoids and mortality: dose-response analyses. (A) Dietary carotenoids and mortality: linear dose-response analysis. The summary RR per 5000 µg/d was 0.88 (95% CI: 0.83, 0.93, I2 = 2%, Pheterogeneity = 0.40, n = 6). (B) Carotenoids in blood and mortality: linear dose-response analysis. The summary RR per 50 µg/dL was 0.69 (95% CI: 0.59, 0.81, I2 = 50%, Pheterogeneity = 0.04, n = 10). (C) Dietary carotenoids and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary carotenoids and mortality (Pnonlinearity = 0.01). (D) Carotenoids in blood and mortality: nonlinear dose-response analysis. There was no evidence of nonlinearity for vitamin C in blood and mortality (Pnonlinearity = 0.73). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines. SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.
FIGURE 7 Dietary intake and blood concentrations of carotenoids and mortality: dose-response analyses. (A) Dietary carotenoids and mortality: linear dose-response analysis. The summary RR per 5000 µg/d was 0.88 (95% CI: 0.83, 0.93, I2 = 2%, Pheterogeneity = 0.40, n = 6). (B) Carotenoids in blood and mortality: linear dose-response analysis. The summary RR per 50 µg/dL was 0.69 (95% CI: 0.59, 0.81, I2 = 50%, Pheterogeneity = 0.04, n = 10). (C) Dietary carotenoids and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary carotenoids and mortality (Pnonlinearity = 0.01). (D) Carotenoids in blood and mortality: nonlinear dose-response analysis. There was no evidence of nonlinearity for vitamin C in blood and mortality (Pnonlinearity = 0.73). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines. SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.CC BY-NC · PubMed Central
FIGURE 8 Dietary β-carotene and blood concentrations of β-carotene and coronary heart disease: dose-response analyses. (A) Dietary β-carotene and coronary heart disease: linear dose-response analysis. The summary RR per 5000 µg/d was 0.82 (95% CI: 0.68, 0.98, I2 = 45%, Pheterogeneity = 0.14, n = 4). (B) β-Carotene in blood and coronary heart disease: linear dose-response analysis. The summary RR per 25 µg/dL was 0.76 (95% CI: 0.62, 0.93, I2 = 22%, Pheterogeneity = 0.28, n = 4). (C) Dietary β-carotene and coronary heart disease: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary β-carotene and coronary heart disease (Pnonlinearity = 0.006). (D) β-Carotene in blood and coronary heart disease: nonlinear dose-response analysis. There was evidence of nonlinearity for β-carotene in blood and coronary heart disease (Pnonlinearity = 0.002). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.
FIGURE 8 Dietary β-carotene and blood concentrations of β-carotene and coronary heart disease: dose-response analyses. (A) Dietary β-carotene and coronary heart disease: linear dose-response analysis. The summary RR per 5000 µg/d was 0.82 (95% CI: 0.68, 0.98, I2 = 45%, Pheterogeneity = 0.14, n = 4). (B) β-Carotene in blood and coronary heart disease: linear dose-response analysis. The summary RR per 25 µg/dL was 0.76 (95% CI: 0.62, 0.93, I2 = 22%, Pheterogeneity = 0.28, n = 4). (C) Dietary β-carotene and coronary heart disease: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary β-carotene and coronary heart disease (Pnonlinearity = 0.006). (D) β-Carotene in blood and coronary heart disease: nonlinear dose-response analysis. There was evidence of nonlinearity for β-carotene in blood and coronary heart disease (Pnonlinearity = 0.002). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.CC BY-NC · PubMed Central
FIGURE 9 (A) Dietary β-carotene and stroke: linear dose-response analyses. The summary RR per 5000 µg/d was 0.81 (95% CI: 0.66, 0.98, I2 = 59%, Pheterogeneity = 0.02, n = 7). (B) β-Carotene in blood and stroke: linear dose-response analysis. The summary RR per 25 µg/dL was 0.85 (95% CI: 0.74, 0.97, I2 = 0%, Pheterogeneity = 0.50, n = 3). (C) Dietary β-carotene and stroke: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary β-carotene and stroke (Pnonlinearity < 0.0001). (D) β-Carotene in blood and stroke: nonlinear dose-response analysis. There was evidence of nonlinearity for β-carotene in blood and stroke (Pnonlinearity = 0.07). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.
FIGURE 9 (A) Dietary β-carotene and stroke: linear dose-response analyses. The summary RR per 5000 µg/d was 0.81 (95% CI: 0.66, 0.98, I2 = 59%, Pheterogeneity = 0.02, n = 7). (B) β-Carotene in blood and stroke: linear dose-response analysis. The summary RR per 25 µg/dL was 0.85 (95% CI: 0.74, 0.97, I2 = 0%, Pheterogeneity = 0.50, n = 3). (C) Dietary β-carotene and stroke: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary β-carotene and stroke (Pnonlinearity < 0.0001). (D) β-Carotene in blood and stroke: nonlinear dose-response analysis. There was evidence of nonlinearity for β-carotene in blood and stroke (Pnonlinearity = 0.07). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.CC BY-NC · PubMed Central
FIGURE 10 Dietary β-carotene and blood concentrations of β-carotene and cardiovascular disease: dose-response analyses. (A) Dietary β-carotene and cardiovascular disease: linear dose-response analysis. The summary RR per 5000 µg/d was 0.87 (95% CI: 0.63, 1.20, I2 = 58%, Pheterogeneity = 0.10, n = 3). (B) β-Carotene in blood and cardiovascular disease: linear dose-response analysis. The summary RR per 25 µg/dL was 0.85 (95% CI: 0.76, 0.95, I2 = 9%, Pheterogeneity = 0.36, n = 7). (C) Dietary β-carotene and cardiovascular disease: nonlinear dose-response analysis. There was no evidence of nonlinearity between dietary β-carotene and cardiovascular disease (Pnonlinearity = 0.51). (D) β-Carotene in blood and cardiovascular disease: nonlinear dose-response analysis. There was evidence of nonlinearity for β-carotene in blood and cardiovascular disease (Pnonlinearity = 0.006). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.
FIGURE 10 Dietary β-carotene and blood concentrations of β-carotene and cardiovascular disease: dose-response analyses. (A) Dietary β-carotene and cardiovascular disease: linear dose-response analysis. The summary RR per 5000 µg/d was 0.87 (95% CI: 0.63, 1.20, I2 = 58%, Pheterogeneity = 0.10, n = 3). (B) β-Carotene in blood and cardiovascular disease: linear dose-response analysis. The summary RR per 25 µg/dL was 0.85 (95% CI: 0.76, 0.95, I2 = 9%, Pheterogeneity = 0.36, n = 7). (C) Dietary β-carotene and cardiovascular disease: nonlinear dose-response analysis. There was no evidence of nonlinearity between dietary β-carotene and cardiovascular disease (Pnonlinearity = 0.51). (D) β-Carotene in blood and cardiovascular disease: nonlinear dose-response analysis. There was evidence of nonlinearity for β-carotene in blood and cardiovascular disease (Pnonlinearity = 0.006). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.CC BY-NC · PubMed Central
FIGURE 11 Dietary β-carotene and blood concentrations of β-carotene and total cancer: dose-response analyses. (A) Dietary β-carotene and total cancer: linear dose-response analysis. The summary RR per 5000 µg/d was 0.96 (95% CI: 0.90, 1.02, I2 = 25%, Pheterogeneity = 0.26, n = 4). (B) β-Carotene in blood and total cancer: linear dose-response analysis. The summary RR per 25 µg/dL was 0.77 (95% CI: 0.68, 0.86, I2 = 0%, Pheterogeneity = 0.64, n = 7). (C) Dietary β-carotene and total cancer: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary β-carotene and total cancer (Pnonlinearity = 0.003). (D) β-Carotene in blood and total cancer: nonlinear dose-response analysis. There was evidence of nonlinearity for β-carotene in blood and total cancer (Pnonlinearity = 0.60). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.
FIGURE 11 Dietary β-carotene and blood concentrations of β-carotene and total cancer: dose-response analyses. (A) Dietary β-carotene and total cancer: linear dose-response analysis. The summary RR per 5000 µg/d was 0.96 (95% CI: 0.90, 1.02, I2 = 25%, Pheterogeneity = 0.26, n = 4). (B) β-Carotene in blood and total cancer: linear dose-response analysis. The summary RR per 25 µg/dL was 0.77 (95% CI: 0.68, 0.86, I2 = 0%, Pheterogeneity = 0.64, n = 7). (C) Dietary β-carotene and total cancer: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary β-carotene and total cancer (Pnonlinearity = 0.003). (D) β-Carotene in blood and total cancer: nonlinear dose-response analysis. There was evidence of nonlinearity for β-carotene in blood and total cancer (Pnonlinearity = 0.60). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.CC BY-NC · PubMed Central
FIGURE 12 Dietary intake and blood concentrations of β-carotene and mortality: dose-response analyses. (A) Dietary β-carotene and mortality: linear dose-response analysis. The summary RR per 5000 µg/d was 0.92 (95% CI: 0.85, 0.98, I2 = 66%, Pheterogeneity = 0.01, n = 6). (B) β-Carotene in blood and mortality: linear dose-response analysis. The summary RR per 25 µg/dL was 0.81 (95% CI: 0.72, 0.90, I2 = 47%, Pheterogeneity = 0.08, n = 7). (C) Dietary β-carotene and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary β-carotene and mortality (Pnonlinearity ≤ 0.0001). (D) β-Carotene in blood and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity for β-carotene in blood and mortality (Pnonlinearity = 0.005). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.
FIGURE 12 Dietary intake and blood concentrations of β-carotene and mortality: dose-response analyses. (A) Dietary β-carotene and mortality: linear dose-response analysis. The summary RR per 5000 µg/d was 0.92 (95% CI: 0.85, 0.98, I2 = 66%, Pheterogeneity = 0.01, n = 6). (B) β-Carotene in blood and mortality: linear dose-response analysis. The summary RR per 25 µg/dL was 0.81 (95% CI: 0.72, 0.90, I2 = 47%, Pheterogeneity = 0.08, n = 7). (C) Dietary β-carotene and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary β-carotene and mortality (Pnonlinearity ≤ 0.0001). (D) β-Carotene in blood and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity for β-carotene in blood and mortality (Pnonlinearity = 0.005). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines.CC BY-NC · PubMed Central
FIGURE 13 Blood concentrations of α-carotene, β-cryptoxanthin, and lycopene and mortality: dose-response analyses. (A) Blood concentrations of α-carotene and mortality: linear dose-response analysis. The summary RR per 10 µg/dL was 0.71 (95% CI: 0.64, 0.79, I2 = 0%, Pheterogeneity = 0.86, n = 5). (B) Blood concentrations of β-cryptoxanthin and mortality: linear dose-response analysis. The summary RR per 15 µg/dL was 0.84 (95% CI: 0.76, 0.94, I2 = 0%, Pheterogeneity = 0.99, n = 3). (C) Blood concentrations of lycopene and mortality: linear dose-response analysis. The summary RR per 25 µg/dL was 0.87 (95% CI: 0.74, 1.02, I2 = 26%, Pheterogeneity = 0.25, n = 5). (D) Blood concentrations of α-carotene and mortality, nonlinear dose-response analysis. There was evidence of nonlinearity between α-carotene in blood and mortality (Pnonlinearity ≤ 0.0001). (E) Blood concentrations of β-cryptoxanthin and mortality: nonlinear dose-response analysis. There was no evidence of nonlinearity for β-cryptoxanthin in blood and mortality (Pnonlinearity = 0.98). (F) Blood concentrations of lycopene and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity for lycopene in blood and mortality (Pnonlinearity = 0.001). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted using restricted cubic splines.
FIGURE 13 Blood concentrations of α-carotene, β-cryptoxanthin, and lycopene and mortality: dose-response analyses. (A) Blood concentrations of α-carotene and mortality: linear dose-response analysis. The summary RR per 10 µg/dL was 0.71 (95% CI: 0.64, 0.79, I2 = 0%, Pheterogeneity = 0.86, n = 5). (B) Blood concentrations of β-cryptoxanthin and mortality: linear dose-response analysis. The summary RR per 15 µg/dL was 0.84 (95% CI: 0.76, 0.94, I2 = 0%, Pheterogeneity = 0.99, n = 3). (C) Blood concentrations of lycopene and mortality: linear dose-response analysis. The summary RR per 25 µg/dL was 0.87 (95% CI: 0.74, 1.02, I2 = 26%, Pheterogeneity = 0.25, n = 5). (D) Blood concentrations of α-carotene and mortality, nonlinear dose-response analysis. There was evidence of nonlinearity between α-carotene in blood and mortality (Pnonlinearity ≤ 0.0001). (E) Blood concentrations of β-cryptoxanthin and mortality: nonlinear dose-response analysis. There was no evidence of nonlinearity for β-cryptoxanthin in blood and mortality (Pnonlinearity = 0.98). (F) Blood concentrations of lycopene and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity for lycopene in blood and mortality (Pnonlinearity = 0.001). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted using restricted cubic splines.CC BY-NC · PubMed Central
FIGURE 14 (A) Dietary intake of vitamin E and mortality: linear dose-response analysis. The summary RR per 5 µg/d was 0.99 (95% CI: 0.96, 1.01, I2 = 42%, Pheterogeneity = 0.10, n = 8). (B) Blood concentrations of α-tocopherol and mortality: linear dose-response analysis. The summary RR per 500 µg/dL was 0.94 (95% CI: 0.90, 0.98, I2 = 43%, Pheterogeneity = 0.09, n = 8). (C) Dietary intake of vitamin E and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin E and mortality (Pnonlinearity < 0.0001). (D) Blood concentrations of α-tocopherol and mortality: nonlinear dose-response analysis. There was indication of nonlinearity for α-tocopherol in blood and mortality (Pnonlinearity = 0.05). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines. SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.
FIGURE 14 (A) Dietary intake of vitamin E and mortality: linear dose-response analysis. The summary RR per 5 µg/d was 0.99 (95% CI: 0.96, 1.01, I2 = 42%, Pheterogeneity = 0.10, n = 8). (B) Blood concentrations of α-tocopherol and mortality: linear dose-response analysis. The summary RR per 500 µg/dL was 0.94 (95% CI: 0.90, 0.98, I2 = 43%, Pheterogeneity = 0.09, n = 8). (C) Dietary intake of vitamin E and mortality: nonlinear dose-response analysis. There was evidence of nonlinearity between dietary vitamin E and mortality (Pnonlinearity < 0.0001). (D) Blood concentrations of α-tocopherol and mortality: nonlinear dose-response analysis. There was indication of nonlinearity for α-tocopherol in blood and mortality (Pnonlinearity = 0.05). Summary RRs and 95% CIs were calculated with the use of random-effects models, and the nonlinear dose-response analyses were conducted with the use of restricted cubic splines. SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 157 references

Cited by

See all 392

Metadata

Authors
Aune, D., Keum, N., Giovannucci, E., Fadnes, L. T., Boffetta, P., Greenwood, D. C., Tonstad, S., Vatten, L. J., Riboli, E., & Norat, T.
Affiliations
  • Oslo University Hospital (NO)
  • Harvard University (US)
  • Brigham and Women's Hospital (US)
  • Haukeland University Hospital (NO)
  • Tisch Cancer Institute (US)
  • University of Leeds (GB)
  • Norwegian University of Science and Technology (NO)
  • Imperial College London (GB)
Corresponding author
Aune, Dagfinn
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2018-11
Volume
108
Issue
5
Pages
1069-1091
ISSN
0002-9165 (ISSN-L)
OpenAlex
W2886490300
Cited by
392
References
157
Citations by year
2026: 27 · 2025: 48 · 2024: 65 · 2023: 64 · 2022: 68 · 2021: 72 · 2020: 31 · 2019: 17
FWCI
3.15
Type
journal article
Language
en
Open access
Licence
Locations
  • American Journal of Clinical Nutrition (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
Keywords
dietary antioxidants, vitamin C, carotenoids, vitamin E, cardiovascular disease, coronary artery disease, stroke, cancer, all-cause mortality, dose-response relationship, dose-response curves, dietary biomarkers, risk mitigation, prospective cohort, effect size heterogeneity, confidence intervals
MeSH terms
Antioxidants, Ascorbic Acid, Cardiovascular Diseases, Carotenoids, Cause of Death, Diet, Feeding Behavior, Humans, Neoplasms, Nutritional Status, Vitamin E, alpha-Tocopherol

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies. https://app.cochat.ai/papers/10.1093/ajcn/nqy097
The paper
Aune, D., Keum, N., Giovannucci, E., Fadnes, L. T., Boffetta, P., Greenwood, D. C., Tonstad, S., Vatten, L. J., Riboli, E., & Norat, T. (2018). Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies. The American Journal of Clinical Nutrition. https://doi.org/10.1093/ajcn/nqy097

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.